State Street reports 5.5% stake in Avalo Therapeutics
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
State Street Corporation filed a Schedule 13G reporting beneficial ownership of common stock of Avalo Therapeutics, Inc. State Street reports beneficial ownership of 2,889,287 shares of Avalo common stock, representing 5.5% of the class.
State Street reports 0 shares with sole voting and dispositive power and 2,837,724 shares with shared voting power, as well as 2,889,287 shares with shared dispositive power. Subsidiaries involved include SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, and State Street Global Advisors Trust Company.
Key Figures
Key Terms
beneficially owned financial
parent holding company financial
investment company financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What percentage of Avalo Therapeutics (AVTX) does State Street Corporation report owning?
What dispositive power does State Street have over Avalo Therapeutics (AVTX) stock?
Which State Street affiliates are associated with the Avalo Therapeutics (AVTX) holdings?
Does State Street report any other person with rights to Avalo Therapeutics (AVTX) dividends or sale proceeds?
AI-generated analysis. How Rhea-AI works. Not financial advice.